Answers are grounded in this paper and cite their sources.
BACKGROUND: Communication failures and fragmented follow-up can compromise care during transitions between hospitals and skilled nursing facilities (SNFs). Available programs differ in setting, transition direction, components, implementation, and outcomes, making it difficult to identify a single best approach. OBJECTIVE: To map structured communication and transitional-care interventions involving hospital-SNF transitions, describe the reported outcome evidence, and identify gaps for future research. METHODS: We conducted a scoping review of randomized, quasi-experimental, observational, quality-improvement, and descriptive studies involving adult hospital-SNF transitions. CENTRAL, CINAHL, Embase, Google Scholar, MEDLINE, PubMed, and Scopus were searched from database inception through March 11, 2026. Data were charted on transition direction, intervention or process components, study design, comparator availability, outcomes, and implementation characteristics. Findings were mapped descriptively; no pooled effect estimate was calculated. RESULTS: Seven US reports met the inclusion criteria: one cluster-randomized trial, four observational or quality-improvement evaluations, and two descriptive transition analyses. Reported components included structured cross-setting communication, early clinician assessment, care-plan review, medication reconciliation, pharmacist involvement, caregiver education, and escalation pathways. The only cluster-randomized implementation trial found no statistically significant reduction in major acute-care outcomes. Reporting of mortality, post-discharge disposition, costs, caregiver-centered outcomes, contemporary digital tools, and long-term implementation was sparse or absent. CONCLUSIONS: This scoping review identifies a small, heterogeneous evidence base and does not establish which transition intervention reduces readmissions. The literature suggests potential value in addressing communication and continuity failures, but direct, contemporary comparative studies with patient-centered and implementation outcomes are needed. TRIAL REGISTRATION: The original protocol was registered in PROSPERO (CRD420261388654). The final report is presented as a scoping review because its objective is evidence mapping rather than pooled effect estimation.
No takes yet. Share an insight, caveat, or question.
Khatiwada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: